We are live on
!
Find out more
EIA
Edgemoor Investment Advisors Portfolio holdings
AUM
$1.27B
1-Year Est. Return
25.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.11%
1 Year Est. Return
+25.83%
3 Year Est. Return
+88.53%
5 Year Est. Return
+105.5%
10 Year Est. Return
+362.63%
AUM
$679M
AUM Growth
+$45.2M
(+7.1%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
141
New
16
Increased
36
Reduced
56
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$11M |
| 2 |
IBM
IBM
|
+$4.87M |
| 3 |
Principal Financial Group
PFG
|
+$4.17M |
| 4 |
Southern Company
SO
|
+$3.77M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$3.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$12M |
| 2 |
Western Union
WU
|
+$8.51M |
| 3 |
NE
Noble Corporation
NE
|
+$3.84M |
| 4 |
Automatic Data Processing
ADP
|
+$1.04M |
| 5 |
GAS
AGL Resources Inc
GAS
|
+$873K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.29% |
| 2 | Energy | 13.93% |
| 3 | Healthcare | 13.15% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Viatris
VTRS
$20.1B
| $232K | 0.03% |
+4,500
| New | +$221K |
|
127
iShares Core S&P 500 ETF
IVV
$898B
| $226K | 0.03% |
+1,146
| New | +$219K |
|
128
Qualcomm
QCOM
$168B
| $218K | 0.03% |
2,753
| – | – |
|
129
Merck
MRK
$318B
| $216K | 0.03% |
3,915
-361
| -8% | -$19.7K |
|
130
Eli Lilly
LLY
$1.05T
| $214K | 0.03% |
+3,450
| New | +$206K |
|
131
Phillips 66
PSX
$81.9B
| $214K | 0.03% |
2,666
+12
| +0.5% | +$988 |
|
132
CVS Health
CVS
$123B
| $212K | 0.03% |
2,818
| – | – |
|
133
Colgate-Palmolive
CL
$74.2B
| $205K | 0.03% |
+3,000
| New | +$201K |
|
134
RTX Corp
RTX
$300B
| $205K | 0.03% |
+2,817
| New | +$207K |
|
135
Deere & Co
DE
$166B
| $203K | 0.03% |
+2,237
| New | +$206K |
|
|
PDT
136
John Hancock Premium Dividend Fund
PDT
$623M
| $136K | 0.02% |
+10,000
| New | +$133K |
|
137
Novavax
NVAX
$1.28B
| $69K | 0.01% |
750
| – | – |
|
138
RLI Corp
RLI
$5.82B
| – | – |
-16,200
| Closed | -$217K |
|
|
WPX
139
DELISTED
WPX Energy, Inc.
WPX
| – | – |
-15,940
| Closed | -$287K |
|
|
NE
140
DELISTED
Noble Corporation
NE
| – | – |
-134,274
| Closed | -$3.84M |
|
|
GAS
141
DELISTED
AGL Resources Inc
GAS
| – | – |
-17,825
| Closed | -$873K |
|
Similar funds
CAM
FBCM
TC
NCM
TWP
TBC
HP
DAM
Edgemoor Investment Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Edgemoor Investment Advisors held 141 positions worth $679M, up 7.1% from $634M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Edgemoor Investment Advisors's Q2 2014 filing shows 16 new, 36 increased, 56 reduced and 4 closed positions. Its largest new stake was Principal Financial Group: 88,575 shares worth $4.47M. The largest sale was Pfizer, an estimated $12M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Energy and Healthcare.
- Edgemoor Investment Advisors's largest Q2 2014 buy was Principal Financial Group: 88,575 shares worth $4.47M.
- Edgemoor Investment Advisors added most to Gilead Sciences in Q2 2014, an estimated $11M increase.
- Edgemoor Investment Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $12M.
- Edgemoor Investment Advisors fully exited Noble Corporation in Q2 2014, selling an estimated $3.84M.
- Edgemoor Investment Advisors's ten largest holdings make up 27% of its $679M portfolio in Q2 2014.
- Edgemoor Investment Advisors opened 16 new positions and closed 4 in Q2 2014.
- Edgemoor Investment Advisors's portfolio value rose 7.1% quarter-over-quarter to $679M.
Based on Edgemoor Investment Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.